BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 7595698)

  • 21. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
    Ribeiro RC; Rivera GK; Hudson M; Mulhern RK; Hancock ML; Kun L; Mahmoud H; Sandlund JT; Crist WM; Pui CH
    J Clin Oncol; 1995 Feb; 13(2):333-8. PubMed ID: 7844594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.
    Tsurusawa M; Katano N; Yamamoto Y; Hirota T; Koizumi S; Watanabe A; Takeda T; Hatae Y; Yatabe M; Mimaya J; Gushiken T; Nishi K; Anami K; Kikuta A; Kanegane H; Asami K; Nishikawa K; Sekine I; Kawano Y; Iwai A; Furuyama T; Ijichi O; Miyake M; Mugishima H; Fujimoto T
    Med Pediatr Oncol; 1999 Apr; 32(4):259-6. PubMed ID: 10102019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
    Tubergen DG; Gilchrist GS; O'Brien RT; Coccia PF; Sather HN; Waskerwitz MJ; Hammond GD
    J Clin Oncol; 1993 Mar; 11(3):520-6. PubMed ID: 8445427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intelligence function in children with acute lymphoblastic leukemia after treatment.
    Qin H; Fu J; Zhang Y; Hu Y; Zhao X
    Chin Med Sci J; 1993 Jun; 8(2):91-4. PubMed ID: 8292807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group.
    Bührer C; Hartmann R; Fengler R; Schober S; Arlt I; Loewke M; Henze G
    Blood; 1994 Jun; 83(12):3468-72. PubMed ID: 8204875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verbal cognitive functioning and learning in girls treated for acute lymphoblastic leukemia by chemotherapy with or without cranial irradiation.
    Précourt S; Robaey P; Lamothe I; Lassonde M; Sauerwein HC; Moghrabi A
    Dev Neuropsychol; 2002; 21(2):173-95. PubMed ID: 12139198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.
    Conklin HM; Krull KR; Reddick WE; Pei D; Cheng C; Pui CH
    J Natl Cancer Inst; 2012 Sep; 104(18):1386-95. PubMed ID: 22927505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurological and psychological sequelae in children with acute lymphoblastic leukemia who had received radiotherapy and intrathecal methotrexate].
    Bernáldez-Ríos R; Villasís-Keever MA; Beltrán-Adame G; García-Ramírez R; Rodríguez-Zepeda MC; Hermida-Gutiérrez I; Arias-Gómez J; Cruz-Luna E
    Gac Med Mex; 1998; 134(2):153-9. PubMed ID: 9618994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: a report from the Children's Cancer Study Group.
    Bleyer WA; Fallavollita J; Robison L; Balsom W; Meadows A; Heyn R; Sitarz A; Ortega J; Miller D; Constine L
    Pediatr Hematol Oncol; 1990; 7(4):329-38. PubMed ID: 2268533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Kaleita TA; Reaman GH; MacLean WE; Sather HN; Whitt JK
    Cancer; 1999 Apr; 85(8):1859-65. PubMed ID: 10223582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up.
    Freeman AI; Boyett JM; Glicksman AS; Brecher ML; Leventhal BG; Sinks LF; Holland JF
    Med Pediatr Oncol; 1997 Feb; 28(2):98-107. PubMed ID: 8986145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy--an MR analysis.
    Matsumoto K; Takahashi S; Sato A; Imaizumi M; Higano S; Sakamoto K; Asakawa H; Tada K
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):913-8. PubMed ID: 7607965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer S; Steuber CP; Camitta B
    J Clin Oncol; 2000 Mar; 18(6):1285-94. PubMed ID: 10715299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia.
    Schrappe M; Reiter A; Riehm H
    J Neurooncol; 1998; 38(2-3):159-65. PubMed ID: 9696367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.